Kinase Inhibitors: Methods and Protocols

KUSTER, B ed.
cover image
Publication
Totowa, NJ : Humana Press, 2012.
ISBN
9781617793363 / e-ISBN:9781617793370
Printed edition: 9781617793363
Edition
1st Edition
Physical Description
XI, 256 p. 47 illus., 11 illus. in color. online resource.
Series
Methods in Molecular Biology Vol 795
URL
Language
eng
 
 
 
04656nam a22004215i 4500
001
 
 
vtls000093996
003
 
 
VRT
005
 
 
20170227123700.0
007
 
 
cr nn 008mamaa
008
 
 
170216s2012    xxu|    s    |||| 0|eng d
020
$a 9781617793363 / e-ISBN:9781617793370 $9 978-1-61779-337-0
024
7
$a 10.1007/978-1-61779-337-0 $2 doi
039
9
$a 201702271237 $b fatimah $c 201702220915 $d ella $c 201702161628 $d fatimah $y 201702161548 $z fatimah
100
1
$a KUSTER, B ed.
245
1
0
$a Kinase Inhibitors: Methods and Protocols
250
$a 1st Edition
264
1
$a Totowa, NJ : $b Humana Press, $c 2012.
300
$a XI, 256 p. 47 illus., 11 illus. in color. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
490
1
$a Methods in Molecular Biology Vol 795
500
$a Springer Protocols
505
0
$a Targeting Cancer with Small Molecular Weight Kinase Inhibitors -- Small Molecule Protein and Lipid Kinase Inhibitors in Inflammation and Specific Models for their Evaluation -- Measuring the Activity of Leucine Rich Repeat Kinase 2 (LRRK2) – A Kinase Involved in Parkinson’s Disease -- Measuring PI3K Lipid Kinase Activity -- A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-box Domain of Polo-like Kinase 1 -- Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology -- Kinase Inhibitor Selectivity Profiling using Differential Scanning Fluorimetry -- Chemoproteomic Characterization of Protein Kinase Inhibitors using Immobilized ATP -- Proteome-wide identification of staurosporine-binding kinases using Capture Compound Mass Spectrometry -- Affinity Purification of Proteins Binding to Kinase Inhibitors Immobilised on Self Assembling Monolayers -- Kinase Inhibitor Profiling using Chemoproteomics -- Covalent Crosslinking of Kinases with Their Corresponding Peptide Substrates -- Receptor Tyrosine Kinase Inhibitor Profiling using Bead-based Multiplex Sandwich Immunoassays -- Monitoring Phosphoproteomic Response To Targeted Kinase Inhibitors Using Reverse-Phase Protein Microarrays -- Measuring Phosphorylation Specific Changes in Response to Kinase Inhibitors in Mammalian Cells Using Quantitative Proteomics -- Investigation of Acquired Resistance to EGFR-Targeted Therapies in Lung Cancer Using cDNA Microarrays.
520
$a Protein and lipid kinases are often the master regulators of cell signaling in eukaryotic systems. The human genome codes for more than 500 of these enzymes and their misregulation has been shown to be involved in the onset and progression of many diseases including cancer and inflammation. Therefore, small molecule kinase inhibitors have become important research tools for the elucidation of the many biological roles of kinases and their mechanisms of action. Kinase inhibitors thus also contribute significantly to the drug pipelines of the pharmaceutical and biotechnology industries and to the growing need to treat cancer and inflammation. In Kinase Inhibitors: Methods and Protocols, experts in kinase biology, drug discovery, and clinical research present a series of exemplary methods that can be used to address the many challenges facing scientists in the discovery and development of kinase inhibitors both for research and clinical use. Written in the highly successful Methods in Molecular Biology™ series format, chapters contain introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and accessible, Kinase Inhibitors: Methods and Protocols aims to provide scientists with modern and relevant methods to accelerate or strengthen their research and drug discovery programs through the utilization of these vital regulators.
541
$a EB01909
650
0
$a MEDICINE
650
0
$a PHARMACOLOGY
650
0
$a BIOMEDICINE
650
1
4
$a METHODS AND PROTOCOLS
650
1
4
$a E-BOOKS
776
0
8
$i Printed edition: $z 9781617793363
830
0
$a Methods in Molecular Biology, Methods and Protocols, $x 1064-3745 ; $v 795
856
4
0
$u http://dx.doi.org/10.1007/978-1-61779-337-0
856
4
0
$u http://www.springerprotocols.com/doiresolver?genre=book&pid=10.1007/978-1-61779-337-0
999
$a VIRTUA
999
$a VTLSSORT0070*0080*0200*0240*1000*2450*2500*2640*3000*3360*3370*3380*3470*4900*5050*5200*5410*6500*6501*6502*6503*6504*7760*8300*8560*8561*5000*9992
Subject
MEDICINE
PHARMACOLOGY
BIOMEDICINE
METHODS AND PROTOCOLS
E-BOOKS
Summary
Protein and lipid kinases are often the master regulators of cell signaling in eukaryotic systems. The human genome codes for more than 500 of these enzymes and their misregulation has been shown to be involved in the onset and progression of many diseases including cancer and inflammation. Therefore, small molecule kinase inhibitors have become important research tools for the elucidation of the many biological roles of kinases and their mechanisms of action. Kinase inhibitors thus also contribute significantly to the drug pipelines of the pharmaceutical and biotechnology industries and to the growing need to treat cancer and inflammation. In Kinase Inhibitors: Methods and Protocols, experts in kinase biology, drug discovery, and clinical research present a series of exemplary methods that can be used to address the many challenges facing scientists in the discovery and development of kinase inhibitors both for research and clinical use. Written in the highly successful Methods in Molecular Biology™ series format, chapters contain introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and accessible, Kinase Inhibitors: Methods and Protocols aims to provide scientists with modern and relevant methods to accelerate or strengthen their research and drug discovery programs through the utilization of these vital regulators.
Table of Contents
Targeting Cancer with Small Molecular Weight Kinase Inhibitors -- Small Molecule Protein and Lipid Kinase Inhibitors in Inflammation and Specific Models for their Evaluation -- Measuring the Activity of Leucine Rich Repeat Kinase 2 (LRRK2) – A Kinase Involved in Parkinson’s Disease -- Measuring PI3K Lipid Kinase Activity -- A Fluorescence Polarization Assay for the Discovery of Inhibitors of the Polo-box Domain of Polo-like Kinase 1 -- Assessment of Hepatotoxicity Potential of Drug Candidate Molecules Including Kinase Inhibitors by Hepatocyte Imaging Assay Technology and Bile Flux Imaging Assay Technology -- Kinase Inhibitor Selectivity Profiling using Differential Scanning Fluorimetry -- Chemoproteomic Characterization of Protein Kinase Inhibitors using Immobilized ATP -- Proteome-wide identification of staurosporine-binding kinases using Capture Compound Mass Spectrometry -- Affinity Purification of Proteins Binding to Kinase Inhibitors Immobilised on Self Assembling Monolayers -- Kinase Inhibitor Profiling using Chemoproteomics -- Covalent Crosslinking of Kinases with Their Corresponding Peptide Substrates -- Receptor Tyrosine Kinase Inhibitor Profiling using Bead-based Multiplex Sandwich Immunoassays -- Monitoring Phosphoproteomic Response To Targeted Kinase Inhibitors Using Reverse-Phase Protein Microarrays -- Measuring Phosphorylation Specific Changes in Response to Kinase Inhibitors in Mammalian Cells Using Quantitative Proteomics -- Investigation of Acquired Resistance to EGFR-Targeted Therapies in Lung Cancer Using cDNA Microarrays.
Notes
Springer Protocols
Methods in Molecular Biology, Methods and Protocols, 1064-3745 ; 795